Vamil Divan
Stock Analyst at Guggenheim
(4.88)
# 364
Out of 4,662 analysts
990
Total ratings
62.8%
Success rate
16.8%
Average return
Main Sectors:
Stocks Rated by Vamil Divan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Reiterated: Buy | $43 | $33.53 | +28.24% | 13 | Aug 16, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $76 | $31.26 | +143.12% | 16 | Aug 14, 2026 | |
| VALN Valneva SE | Maintained: Buy | $11 | $6.82 | +61.29% | 10 | Aug 13, 2026 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $37 → $25 | $5.45 | +358.72% | 9 | Aug 12, 2026 | |
| SVRA Savara | Reiterated: Buy | $11 | $5.49 | +100.36% | 10 | Aug 11, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $47 | $21.23 | +121.38% | 9 | Aug 10, 2026 | |
| AMGN Amgen | Maintained: Hold | $343 → $388 | $433.73 | -10.54% | 9 | Aug 7, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Buy | $124 → $119 | $77.40 | +53.75% | 22 | Aug 7, 2026 | |
| INSM Insmed | Reiterated: Buy | $207 → $205 | $125.08 | +63.90% | 19 | Aug 6, 2026 | |
| PFE Pfizer | Maintained: Buy | $35 → $31 | $27.79 | +11.55% | 119 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $270 → $287 | $267.37 | +7.34% | 55 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $75 | $64.46 | +16.35% | 30 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $146 | $148.99 | -2.01% | 51 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $261 → $288 | $261.83 | +10.00% | 130 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $43 | $18.04 | +138.36% | 1 | Jul 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $3 | $5.22 | -42.53% | 5 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $9.28 | +61.64% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 38.00 | kr 11.04 | +244.20% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.52 | +127.27% | 9 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $1.42 | n/a | 2 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.96 | n/a | 4 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €9.00 | €14.10 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.1575 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $26 | $4.64 | n/a | 6 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1,244.40 | n/a | 95 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 13 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $109.51 | n/a | 5 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.60 | n/a | 7 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 | $208.03 | n/a | 15 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $8.35 | n/a | 31 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $27 | $29.04 | n/a | 20 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $48.02 | n/a | 72 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $10 | $3.19 | n/a | 11 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $106.12 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $738 | $826.64 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $141 | $45.15 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $265 | $540.26 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $16.95 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $36.84 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 | $152.93 | n/a | 30 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $25.35 | n/a | 4 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $33.45 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.19 | n/a | 2 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.14 | n/a | 3 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $36.81 | n/a | 55 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $59 → $55 | $65.47 | n/a | 45 | May 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $28.25 | n/a | 10 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $86.86 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $14.33 | n/a | 6 | Aug 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $312 → $322 | $214.35 | n/a | 2 | Aug 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $0.2089 | n/a | 1 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $35 → $30 | $3.22 | n/a | 6 | Feb 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $198 → $230 | $213.24 | n/a | 7 | Jan 28, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $143.44 | n/a | 1 | Apr 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $156.30 | n/a | 1 | Mar 5, 2013 |
Assembly Biosciences
Aug 16, 2026
Reiterated: Buy
Price Target: $43
Current: $33.53
Upside: +28.24%
Vera Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $76
Current: $31.26
Upside: +143.12%
Valneva SE
Aug 13, 2026
Maintained: Buy
Price Target: $11
Current: $6.82
Upside: +61.29%
Unicycive Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $37 → $25
Current: $5.45
Upside: +358.72%
Savara
Aug 11, 2026
Reiterated: Buy
Price Target: $11
Current: $5.49
Upside: +100.36%
Jade Biosciences
Aug 10, 2026
Reiterated: Buy
Price Target: $47
Current: $21.23
Upside: +121.38%
Amgen
Aug 7, 2026
Maintained: Hold
Price Target: $343 → $388
Current: $433.73
Upside: -10.54%
ANI Pharmaceuticals
Aug 7, 2026
Reiterated: Buy
Price Target: $124 → $119
Current: $77.40
Upside: +53.75%
Insmed
Aug 6, 2026
Reiterated: Buy
Price Target: $207 → $205
Current: $125.08
Upside: +63.90%
Pfizer
Aug 6, 2026
Maintained: Buy
Price Target: $35 → $31
Current: $27.79
Upside: +11.55%
Aug 5, 2026
Reiterated: Buy
Price Target: $270 → $287
Current: $267.37
Upside: +7.34%
Aug 5, 2026
Reiterated: Buy
Price Target: $65 → $75
Current: $64.46
Upside: +16.35%
Aug 4, 2026
Reiterated: Buy
Price Target: $145 → $146
Current: $148.99
Upside: -2.01%
Aug 3, 2026
Reiterated: Buy
Price Target: $261 → $288
Current: $261.83
Upside: +10.00%
Jul 19, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $18.04
Upside: +138.36%
Jul 1, 2026
Maintained: Buy
Price Target: $5 → $3
Current: $5.22
Upside: -42.53%
Jun 25, 2026
Reiterated: Buy
Price Target: $15
Current: $9.28
Upside: +61.64%
May 6, 2026
Reiterated: Buy
Price Target: kr 38.00
Current: kr 11.04
Upside: +244.20%
Mar 20, 2026
Maintained: Buy
Price Target: $8
Current: $3.52
Upside: +127.27%
Jul 13, 2025
Maintained: Buy
Price Target: $6 → $7
Current: $1.42
Upside: n/a
May 29, 2025
Maintained: Hold
Price Target: n/a
Current: $10.96
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: €9.00
Current: €14.10
Upside: n/a
May 6, 2024
Maintained: Hold
Price Target: n/a
Current: $0.1575
Upside: n/a
Jun 15, 2023
Maintained: Buy
Price Target: $50 → $26
Current: $4.64
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $1,244.40
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $109.51
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $8.60
Upside: n/a
Jun 27, 2022
Maintained: Buy
Price Target: $49
Current: $208.03
Upside: n/a
Jun 21, 2022
Maintained: Buy
Price Target: $15
Current: $8.35
Upside: n/a
Jun 17, 2022
Rated: Hold
Price Target: $27
Current: $29.04
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $36
Current: $48.02
Upside: n/a
May 24, 2022
Maintained: Buy
Price Target: $20 → $10
Current: $3.19
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $52
Current: $106.12
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $738
Current: $826.64
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $141
Current: $45.15
Upside: n/a
May 22, 2022
Initiated Coverage: Hold
Price Target: $265
Current: $540.26
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $12
Current: $16.95
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $6
Current: $36.84
Upside: n/a
May 4, 2022
Maintained: Hold
Price Target: $95
Current: $152.93
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $58
Current: $25.35
Upside: n/a
May 7, 2021
Maintained: Buy
Price Target: $37
Current: $33.45
Upside: n/a
Jul 10, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $1.19
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $4.14
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $36.81
Upside: n/a
May 29, 2019
Maintained: Hold
Price Target: $59 → $55
Current: $65.47
Upside: n/a
Dec 13, 2018
Upgraded: Buy
Price Target: n/a
Current: $28.25
Upside: n/a
Nov 27, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $86.86
Upside: n/a
Aug 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $14.33
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $312 → $322
Current: $214.35
Upside: n/a
Oct 26, 2015
Rated: Buy
Price Target: $29
Current: $0.2089
Upside: n/a
Feb 4, 2015
Downgraded: Sell
Price Target: $35 → $30
Current: $3.22
Upside: n/a
Jan 28, 2015
Reiterated: Buy
Price Target: $198 → $230
Current: $213.24
Upside: n/a
Apr 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $143.44
Upside: n/a
Mar 5, 2013
Initiated Coverage: Buy
Price Target: $48
Current: $156.30
Upside: n/a